1471. Vidaza-H-C-978-PSUV-0029 1472. Telmisartan Teva Pharma-H-C-2511-A31-0006 : Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed explanation of the scientific grounds for the differences from the PRAC ... 1473. Aerius-H-C-PSUSA-00000962-201607 1474. Revlimid-H-C-717-PSUV-0069 1475. Aprovel-H-C-PSUSA-00001782/201508 1476. Methylthioninium chloride Proveblue-H-C-PSUSA-00002029-201505 1477. Bydureon-H-C-PSUSA-00009147-201503 1478. Betmiga-H-C-2388-PSUV-0007 1479. Javlor-H-C-983-II-11 1480. Tenkasi-H-C-PSUSA-00010368-201709 1481. Efficib-H-C-PSUSA-00002003-201708 1482. Zonegran-H-C-PSUSA-00003152-201703 1483. Xiliarx-H-C-PSUSA-3113-201502 1484. Rivastigmine Sandoz-H-C-PSUSA-00002654-201501 : Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 1485. Jardiance-H-C-PSUSA-00010388-201610 1486. Imbruvica- H-C-PSUSA-00010301-201605 1487. Emend-H-C-527-PSUV-0042 1488. Pantozol Control-H-C-PSUSA-00002285-201708 1489. Abilify-H-C-471-PSU-0063 1490. Brintellix-H-C-2717-PSUV-0003 1491. Vargatef-H-C-PSUSA-00010318-201710 1492. Esmya-H-C-PSUSA-00009325-201702 1493. Afinitor-H-C-1038-PSUV-0039 1494. Vipdomet-H-C-2654-PSUV-0008: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 1495. Yervoy-H-C-PSUSA-00009200-201409 1496. Silodyx-H-C-1209-PSUV-0013 1497. Docetaxel Winthrop- H-C-PSUSA-00001152-201611 1498. Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 1499. Jentadueto (linagliptin / metformin) 1500. Yervoy-H-C-PSUSA-00009200-201503: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation